Multicenter evaluation of pharmacologic management and outcomes associated with severe resistant alcohol withdrawal
- 1 April 2015
- journal article
- research article
- Published by Elsevier in Journal of Critical Care
- Vol. 30 (2) , 405-409
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Use of dexmedetomidine for the treatment of alcohol withdrawal syndrome in critically ill patients: a retrospective case seriesJournal of Anesthesia, 2012
- Dexmedetomidine as adjunct treatment for severe alcohol withdrawal in the ICUAnnals of Intensive Care, 2012
- Phenobarbital Treatment in a Patient with Resistant Alcohol Withdrawal SyndromePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2009
- Dexmedetomidine Infusion as Adjunctive Therapy to Benzodiazepines for Acute Alcohol WithdrawalAnnals of Pharmacotherapy, 2008
- A strategy of escalating doses of benzodiazepines and phenobarbital administration reduces the need for mechanical ventilation in delirium tremens*Critical Care Medicine, 2007
- Dexmedetomidine as an adjuvant in the treatment of alcohol withdrawal delirium: a case reportGeneral Hospital Psychiatry, 2006
- Resistant alcohol withdrawal: Does an unexpectedly large sedative requirement identify these patients early?Journal of Medical Toxicology, 2006
- EFNS guideline on the diagnosis and management of alcohol‐related seizures: report of an EFNS task forceEuropean Journal of Neurology, 2005
- Management of Delirium TremensJournal of Intensive Care Medicine, 2005
- Management of Alcohol Withdrawal DeliriumAn Evidence-Based Practice GuidelineArchives of internal medicine (1960), 2004